Apex Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $4.27M | Sell |
11,855
-1,459
| -11% | -$526K | 0.09% | 158 |
|
|
2015
Q4 | $7.23M | Buy |
13,314
+387
| +3% | +$210K | 0.16% | 127 |
|
|
2015
Q3 | $6.01M | Buy |
12,927
+3,763
| +41% | +$1.75M | 0.14% | 132 |
|
|
2015
Q2 | $4.68M | Sell |
9,164
-91
| -1% | -$46.4K | 0.1% | 154 |
|
|
2015
Q1 | $4.18M | Sell |
9,255
-740
| -7% | -$334K | 0.1% | 162 |
|
|
2014
Q4 | $4.1M | Sell |
9,995
-118
| -1% | -$48.4K | 0.11% | 153 |
|
|
2014
Q3 | $3.65M | Buy |
10,113
+947
| +10% | +$341K | 0.11% | 149 |
|
|
2014
Q2 | $2.59M | Sell |
9,166
-359
| -4% | -$101K | 0.08% | 168 |
|
|
2014
Q1 | $2.86M | Buy |
9,525
+73
| +0.8% | +$21.9K | 0.1% | 157 |
|
|
2013
Q4 | $2.6M | Buy |
9,452
+579
| +7% | +$159K | 0.1% | 149 |
|
|
2013
Q3 | $2.78M | Buy |
+8,873
| New | +$2.78M | 0.12% | 132 |
|